Insider Trading Alert - WebMD Health Corporation And 4 Others Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Sept. 13, 2013, 141 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $99.99 to $478,779,119.37.

Highlighted Stocks Traded by Insiders:

WebMD Health Corporation (WBMD) - FREE Research Report

Manning James V who is Director at WebMD Health Corporation sold 6,888 shares at $33.47 on Sept. 13, 2013. Following this transaction, the Director owned 0 shares meaning that the stake was reduced by 100% with the 6,888 share transaction.

The shares most recently traded at $31.12, down $2.35, or 7.56% since the insider transaction. Historical insider transactions for WebMD Health Corporation go as follows:

  • 4-Week # shares sold: 63,747
  • 12-Week # shares sold: 230,842
  • 24-Week # shares sold: 230,842

The average volume for WebMD Health Corporation has been 865,400 shares per day over the past 30 days. WebMD Health Corporation has a market cap of $1.6 billion and is part of the technology sector and computer software & services industry. Shares are up 121.27% year to date as of the close of trading on Friday.

WebMD Health Corp. provides health information services to consumers, physicians and other healthcare professionals, employers, and health plans through its public and private online portals, mobile platforms, and health-focused publications in the United States. Currently there are 2 analysts that rate WebMD Health Corporation a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WBMD - FREE

TheStreet Quant Ratings rates WebMD Health Corporation as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income and revenue growth. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and generally higher debt management risk. Get the full WebMD Health Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Fleetcor Technologies (FLT) - FREE Research Report

Stull Steven T who is Director at Fleetcor Technologies sold 20,000 shares at $107.07 on Sept. 13, 2013. Following this transaction, the Director owned 58,237 shares meaning that the stake was reduced by 25.56% with the 20,000 share transaction.

Clarke Ronald who is CEO & President at Fleetcor Technologies sold 750,000 shares at $104.86 on Sept. 13, 2013. Following this transaction, the CEO & President owned 411,283 shares meaning that the stake was reduced by 64.58% with the 750,000 share transaction.

The shares most recently traded at $109.00, up $4.14, or 3.8% since the insider transaction. Historical insider transactions for Fleetcor Technologies go as follows:

  • 4-Week # shares sold: 2.0 million
  • 12-Week # shares sold: 2.0 million
  • 24-Week # shares sold: 4.5 million

The average volume for Fleetcor Technologies has been 693,200 shares per day over the past 30 days. Fleetcor Technologies has a market cap of $8.8 billion and is part of the services sector and diversified services industry. Shares are up 99.89% year to date as of the close of trading on Friday.

FleetCor Technologies, Inc. provides fuel cards and workforce payment products and services to businesses, commercial fleets, oil companies, petroleum marketers, and government entities in North America, Latin America, and Europe. The company has a P/E ratio of 35.4. Currently there are 3 analysts that rate Fleetcor Technologies a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FLT - FREE

TheStreet Quant Ratings rates Fleetcor Technologies as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Fleetcor Technologies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Baxter International (BAX) - FREE Research Report

Shapazian Carole J who is Director at Baxter International sold 1,941 shares at $71.58 on Sept. 13, 2013. Following this transaction, the Director owned 5,111 shares meaning that the stake was reduced by 27.52% with the 1,941 share transaction.

The shares most recently traded at $72.51, up $0.93, or 1.28% since the insider transaction. Historical insider transactions for Baxter International go as follows:

  • 24-Week # shares sold: 1,000

The average volume for Baxter International has been 2.7 million shares per day over the past 30 days. Baxter International has a market cap of $38.9 billion and is part of the health care sector and health services industry. Shares are up 7.68% year to date as of the close of trading on Friday.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The stock currently has a dividend yield of 2.74%. The company has a P/E ratio of 17.9. Currently there are 12 analysts that rate Baxter International a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BAX - FREE

TheStreet Quant Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Baxter International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Royal Caribbean Cruises (RCL) - FREE Research Report

Reilly William K who is Director at Royal Caribbean Cruises sold 8,000 shares at $39.02 on Sept. 13, 2013. Following this transaction, the Director owned 8,926 shares meaning that the stake was reduced by 47.26% with the 8,000 share transaction.

The shares most recently traded at $39.77, up $0.75, or 1.88% since the insider transaction. Historical insider transactions for Royal Caribbean Cruises go as follows:

  • 4-Week # shares sold: 11,483
  • 12-Week # shares sold: 67,024
  • 24-Week # shares sold: 79,109

The average volume for Royal Caribbean Cruises has been 1.7 million shares per day over the past 30 days. Royal Caribbean Cruises has a market cap of $8.6 billion and is part of the services sector and leisure industry. Shares are up 14.56% year to date as of the close of trading on Friday.

Royal Caribbean Cruises Ltd. operates as a cruise company worldwide. It owns five cruise brands comprising Royal Caribbean International, Celebrity Cruises, Pullmantur, Azamara Club Cruises, and CDF Croisieres de France. The stock currently has a dividend yield of 2.57%. The company has a P/E ratio of 114.6. Currently there are 9 analysts that rate Royal Caribbean Cruises a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RCL - FREE

TheStreet Quant Ratings rates Royal Caribbean Cruises as a hold. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, poor profit margins and generally higher debt management risk. Get the full Royal Caribbean Cruises Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Kennametal (KMT) - FREE Research Report

Hanna Steven R who is Vice President at Kennametal sold 3,000 shares at $46.00 on Sept. 13, 2013. Following this transaction, the Vice President owned 4,955 shares meaning that the stake was reduced by 37.71% with the 3,000 share transaction.

The shares most recently traded at $47.83, up $1.83, or 3.83% since the insider transaction. Historical insider transactions for Kennametal go as follows:

  • 4-Week # shares sold: 4,777
  • 12-Week # shares sold: 14,309
  • 24-Week # shares sold: 56,977

The average volume for Kennametal has been 487,500 shares per day over the past 30 days. Kennametal has a market cap of $3.6 billion and is part of the industrial goods sector and industrial industry. Shares are up 15% year to date as of the close of trading on Friday.

Kennametal Inc. manufactures and supplies tooling, engineered components, and advanced materials consumed in production processes worldwide. The company operates in two segments, Industrial and Infrastructure. The stock currently has a dividend yield of 1.57%. The company has a P/E ratio of 18.2. Currently there are 6 analysts that rate Kennametal a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KMT - FREE

TheStreet Quant Ratings rates Kennametal as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, solid stock price performance, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Kennametal Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists

NYSE Suspends Trading for Some Shares of Nasdaq-Listed Amazon, Alphabet

NYSE Suspends Trading for Some Shares of Nasdaq-Listed Amazon, Alphabet